Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
11.91
-0.47 (-3.76%)
Mar 31, 2025, 1:41 PM EDT - Market open

Zymeworks Statistics

Total Valuation

Zymeworks has a market cap or net worth of $828.31 million. The enterprise value is $555.00 million.

Market Cap 828.31M
Enterprise Value 555.00M

Important Dates

The last earnings date was Wednesday, March 5, 2025, after market close.

Earnings Date Mar 5, 2025
Ex-Dividend Date n/a

Share Statistics

Zymeworks has 69.58 million shares outstanding. The number of shares has increased by 10.19% in one year.

Current Share Class 69.58M
Shares Outstanding 69.58M
Shares Change (YoY) +10.19%
Shares Change (QoQ) -1.89%
Owned by Insiders (%) 0.20%
Owned by Institutions (%) 58.26%
Float 39.12M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 12.30
Forward PS 9.38
PB Ratio 2.52
P/TBV Ratio 2.67
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 7.27
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.05.

Current Ratio 3.40
Quick Ratio 3.19
Debt / Equity 0.05
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -30.54% and return on invested capital (ROIC) is -17.92%.

Return on Equity (ROE) -30.54%
Return on Assets (ROA) -14.57%
Return on Invested Capital (ROIC) -17.92%
Return on Capital Employed (ROCE) -32.47%
Revenue Per Employee $266,797
Profits Per Employee -$429,003
Employee Count 286
Asset Turnover 0.15
Inventory Turnover n/a

Taxes

In the past 12 months, Zymeworks has paid $6.08 million in taxes.

Income Tax 6.08M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +13.97% in the last 52 weeks. The beta is 1.13, so Zymeworks's price volatility has been higher than the market average.

Beta (5Y) 1.13
52-Week Price Change +13.97%
50-Day Moving Average 13.54
200-Day Moving Average 12.57
Relative Strength Index (RSI) 40.85
Average Volume (20 Days) 728,591

Short Selling Information

The latest short interest is 5.42 million, so 7.78% of the outstanding shares have been sold short.

Short Interest 5.42M
Short Previous Month 3.96M
Short % of Shares Out 7.78%
Short % of Float 13.84%
Short Ratio (days to cover) 8.16

Income Statement

In the last 12 months, Zymeworks had revenue of $76.30 million and -$122.70 million in losses. Loss per share was -$1.62.

Revenue 76.30M
Gross Profit -60.20M
Operating Income -121.70M
Pretax Income -115.98M
Net Income -122.70M
EBITDA -113.02M
EBIT -121.70M
Loss Per Share -$1.62
Full Income Statement

Balance Sheet

The company has $225.78 million in cash and $18.53 million in debt, giving a net cash position of $305.67 million or $4.39 per share.

Cash & Cash Equivalents 225.78M
Total Debt 18.53M
Net Cash 305.67M
Net Cash Per Share $4.39
Equity (Book Value) 338.77M
Book Value Per Share 4.91
Working Capital 212.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$110.04 million and capital expenditures -$1.99 million, giving a free cash flow of -$112.04 million.

Operating Cash Flow -110.04M
Capital Expenditures -1.99M
Free Cash Flow -112.04M
FCF Per Share -$1.61
Full Cash Flow Statement

Margins

Gross margin is -78.89%, with operating and profit margins of -159.49% and -160.80%.

Gross Margin -78.89%
Operating Margin -159.49%
Pretax Margin -152.82%
Profit Margin -160.80%
EBITDA Margin -148.11%
EBIT Margin -159.49%
FCF Margin n/a

Dividends & Yields

Zymeworks does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.19%
Shareholder Yield n/a
Earnings Yield -14.26%
FCF Yield -13.02%

Analyst Forecast

The average price target for Zymeworks is $19.50, which is 63.80% higher than the current price. The consensus rating is "Buy".

Price Target $19.50
Price Target Difference 63.80%
Analyst Consensus Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 16.11%
EPS Growth Forecast (5Y) -10.21%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Zymeworks has an Altman Z-Score of 1.15 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.15
Piotroski F-Score 3